Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) has provided an update.
Shanghai Bio-Heart Biological Technology Co., Ltd. has announced a major transaction involving the deemed disposal of an equity interest in a subsidiary. Additionally, the company has proposed amendments to its Articles of Association and scheduled an Extraordinary General Meeting and Class Meetings to discuss and vote on these matters. The implications of these changes could potentially affect the company’s operations and strategic direction.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-Heart Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biological technology industry. The company is engaged in developing innovative solutions and technologies within its sector, focusing on growth and expansion in the market.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
See more data about 2185 stock on TipRanks’ Stock Analysis page.
